Original Articles
Copyright ©The Author(s) 2001.
World J Gastroenterol. Apr 15, 2001; 7(2): 222-227
Published online Apr 15, 2001. doi: 10.3748/wjg.v7.i2.222
Figure 3
Figure 3 Decrease of hemoglobin of 40 patients (34 non-responders and 13 relapsers to IFN monotherapy) who continued on combination therapy with IFN and “low-dose” ribavirin.